Do patients with axial spondyloarthritis with active disease suffer from greater disease burden and work impairment? Results from the International Map of Axial Spondyloarthritis (IMAS) Marco Garrido-Cumbrera, Denis Poddubnyy, Fernando Sommerfleck, Christine Bundy, Souzi Makri, José Correa-Fernández, Shashank Akerkar, Jo Lowe, Elie Karam, Victoria Navarro-Compán

Effectiveness of a checklist for the control of the disease activity in patients with axial spondyloarthritis Raquel Almodóvar, Elia Pérez-Fernández, Marta Valero, Virginia Villaverde, Laura González, Beatriz Joven Ibáñez, Eva Tomero Muriel, Alejandro Prada Ojeda, M.a Teresa Navio, Laura Cebrián Méndez, Leticia Lojo, Ramón Mazzucchelli, Pedro Zarco Montejo

One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry Clementina López-Medina, Lucía Otero-Varela, Fernando Sánchez-Alonso, Vega Jovaní, Lorena Expósito-Pérez, Sheila Melchor-Díaz, Yanira Pérez-Vera, Paula Pretel-Ruiz, Javier Manero, Antonio Mera-Varela, Lourdes Mateo, Dolores Ruiz-Montesino, José Andrés Lorenzo-Martín, Teresa Pedraz-Penalva, Isabel Castrejón